Optune plus transducer
Ended Awarded Last action
- Contract number
- 36C24926F0047
- Awardee
-
Novocure Inc. UEI P3S3GK3DTUA8
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $16,583
Award facts
- Contract value 100% obligated
- $16,582.91 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portsmouth, NH 03801, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$33,166 | |
| Original award | $49,749 |
About this award
Novocure Inc. was awarded a delivery order valued at $16,582.91 for Optune Plus Transducers under a firm fixed-price contract on October 16, 2025, with an ultimate completion date of December 20, 2025. The delivery order is issued under Novocure's existing GSA Federal Supply Schedule contract for Medical Equipment and Supplies (FSS-65-II-A), a $28.85 million multiple-award vehicle established on November 1, 2022, and extending through October 31, 2027. The contract is funded by Veterans Integrated Service Network 9 (VISN 9), a civilian agency component of the Department of Veterans Affairs, with performance of work to take place in Portsmouth, New Hampshire. No set-aside designation was applied to this award, and Novocure is performing as the prime contractor without subcontractors.
Novocure Inc., a foreign-owned medical device manufacturer, specializes in Tumor Treating Fields (TTFields) technology through its FDA-approved Optune system for treating solid tumors including glioblastoma and mesothelioma. The transducers being procured under this delivery order are component elements of Novocure's non-invasive cancer therapy platform, which the company supplies to VA medical centers nationwide to expand veterans' access to advanced oncological treatment options. Novocure's consistent delivery of specialized medical devices directly to VA facilities through firm fixed-price contracts reflects the specialized and proprietary nature of these cancer treatment technologies within the federal healthcare marketplace.
Quick answers
Who was awarded contract 36C24926F0047?
36C24926F0047 was awarded to Novocure Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on October 16, 2025.
How much is contract 36C24926F0047 worth?
The government has obligated $16,583 on 36C24926F0047.
Is contract 36C24926F0047 an order under another contract?
Yes. 36C24926F0047 is a delivery order under 36F79723D0016, a federal supply schedule, on Medical Equipment and Supplies (FSS-65-II-A).
Was contract 36C24926F0047 competed?
The extent of competition for 36C24926F0047 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award